These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 29350055)

  • 21. Advances in developing therapeutic strategies for Alzheimer's disease.
    Nguyen TT; Nguyen TTD; Nguyen TKO; Vo TK; Vo VG
    Biomed Pharmacother; 2021 Jul; 139():111623. PubMed ID: 33915504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted Nanoparticles for the Treatment of Alzheimer's Disease.
    Martín-Rapun R; De Matteis L; Ambrosone A; Garcia-Embid S; Gutierrez L; de la Fuente JM
    Curr Pharm Des; 2017; 23(13):1927-1952. PubMed ID: 28025949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
    Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
    Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomaterials in treatment of Alzheimer's disease.
    Agrawal M; Prathyusha E; Ahmed H; Dubey SK; Kesharwani P; Singhvi G; Naidu VGM; Alexander A
    Neurochem Int; 2021 May; 145():105008. PubMed ID: 33684545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery.
    Bahadur S; Sachan N; Harwansh RK; Deshmukh R
    Curr Pharm Des; 2020; 26(12):1331-1344. PubMed ID: 32160843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted delivery of nano-therapeutics for major disorders of the central nervous system.
    Gao H; Pang Z; Jiang X
    Pharm Res; 2013 Oct; 30(10):2485-98. PubMed ID: 23797465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-articular targeting of nanomaterials for the treatment of osteoarthritis.
    Brown S; Kumar S; Sharma B
    Acta Biomater; 2019 Jul; 93():239-257. PubMed ID: 30862551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
    Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
    Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current Limitations in the Treatment of Parkinson's and Alzheimer's Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers.
    Tonda-Turo C; Origlia N; Mattu C; Accorroni A; Chiono V
    Curr Med Chem; 2018; 25(41):5755-5771. PubMed ID: 29473493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered therapeutic proteins for sustained-release drug delivery systems.
    Nguyen TTK; Pham KY; Yook S
    Acta Biomater; 2023 Nov; 171():131-154. PubMed ID: 37717712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galantamine-loaded solid-lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations.
    Misra S; Chopra K; Sinha VR; Medhi B
    Drug Deliv; 2016 May; 23(4):1434-43. PubMed ID: 26405825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
    Jojo GM; Kuppusamy G; De A; Karri VVSNR
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1061-1072. PubMed ID: 30922126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.
    Banks WA
    Adv Drug Deliv Rev; 2012 May; 64(7):629-39. PubMed ID: 22202501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating Alzheimer's disease using nanoparticle-mediated drug delivery strategies/systems.
    Roghani AK; Garcia RI; Roghani A; Reddy A; Khemka S; Reddy RP; Pattoor V; Jacob M; Reddy PH; Sehar U
    Ageing Res Rev; 2024 Jun; 97():102291. PubMed ID: 38614367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applications of Nanoparticles in Alzheimer's Disease.
    Liu Y; Shen Y
    J Alzheimers Dis; 2023; 96(2):459-471. PubMed ID: 37807779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery.
    Sharma HS; Castellani RJ; Smith MA; Sharma A
    Int Rev Neurobiol; 2012; 102():47-90. PubMed ID: 22748826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy.
    Panahi Y; Mohammadhosseini M; Abadi AJ; Akbarzadeh A; Mellatyar H
    Drug Res (Stuttg); 2016 Nov; 66(11):580-586. PubMed ID: 27701713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles-Focus on Alzheimer's and Parkinson's disease.
    Hernando S; Santos-Vizcaíno E; Igartua M; Hernandez RM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1898. PubMed ID: 37157144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.